The aim of this guideline is to provide an update of the evidence-based recommendations of the guideline produced by the CNS in 2019 regarding the use of emerging therapies for adult patients with metastatic brain tumors.
This systematic review provides evidence-based recommendations for adult patients with metastatic brain tumors related to targeted therapy and immunotherapy, LITT and radiosensitizers, interstitial modalities and HIFU.
CNS will perform another planned update of the entire Brain Metastases guideline in 2026 to maintain currency and accuracy of these guidelines.
READ HERE
LISTEN TO THE PODCAST